Ocean Biomedical, Inc.
NASDAQ:OCEA
0.0105 (USD) • At close May 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Operating Activities: | ||||||
| Net Income
| -9.48 | -114.466 | -0.958 | -62.344 | -1.653 | -0.232 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.745 | 1.205 | 0 | 56.55 | 0 | 0 |
| Change In Working Capital
| 1.043 | 1.181 | 1.735 | 4.741 | 1.589 | 0.232 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.869 | 1.233 | 0.29 | 0 | 0 | 0 |
| Other Working Capital
| 0.174 | -0.052 | 1.445 | 4.741 | 0 | 0 |
| Other Non Cash Items
| 3.512 | 102.651 | -1.524 | -0.002 | 0 | 0 |
| Operating Cash Flow
| -4.18 | -9.429 | -0.747 | -1.053 | -0.064 | 0 |
| Investing Activities: | ||||||
| Investments In Property Plant And Equipment
| 0 | 0 | -0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | -107.1 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | -2.1 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | -2.1 | -107.1 | 0 | 0 |
| Financing Activities: | ||||||
| Debt Repayment
| 0 | 6.808 | 2.1 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 15.768 | 0 | 1.017 | 0 | 0 |
| Common Stock Repurchased
| 0 | -64.282 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 3.4 | 52.105 | 0 | 0.096 | 0.064 | 0 |
| Financing Cash Flow
| 3.4 | 10.399 | 2.1 | 1.113 | 0.064 | 0 |
| Other Information: | ||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 107.1 | 0 | 0 |
| Net Change In Cash
| -0.78 | 0.97 | -0.747 | 0.06 | 0 | 0 |
| Cash At End Of Period
| 0.224 | 1.004 | 0.328 | 0.06 | 0 | 0 |